Table 1.
Summary of recommendations for low, moderate, and high risk lesions by named algorithm based apps identified by this review
| App | Platform; app availability | Low risk | Moderate risk | High risk | Comparison |
|---|---|---|---|---|---|
| Currently available apps | |||||
| skinScan* | iOS; Europe (CE marked), Australia, and New Zealand | “Typical” | — | “Atypical” | — |
| SkinVision† with or without questionnaire | iOS, Android; Europe (CE marked) | “Not much to worry about”; monitor for any changes | “Some chaotic growth”; consult a doctor | “Abnormal growth”; consult a doctor asap | H v M/L H/M v L |
| Apps with uncertain availability (urls not accessible) | |||||
| Dr Mole‡§ | Android/Amazon; app last updated 2 August 201*¶ | No specific action recommended | Consult specialist | Consult specialist immediately | H/M v L |
| SpotMole‡ | Android; app last updated 30 March 2016** | Okay; see a doctor if still concerned | — | “Problematic”; consult doctor | H v L |
| Apps withdrawn from market | |||||
| MelApp‡ | iOS, Android | Low | Medium | High | H v M/L H/M v L |
| Mole Detective‡ | iOS, Android | Monitor; no consultation needed | “Symptoms of melanoma”; monitor and schedule annual dermatology appointment | “Several symptoms of melanoma”; consult dermatologist | H v M/L H/M v L |
CE=Conformit Europenne; H=high risk; L=low risk; M=moderate risk.
This is the TeleSkin skinScan app and not the SkinScan app evaluated by Chadwick and colleagues.23 No published peer reviewed study was found evaluating the TeleSkin skinScan app. TeleSkin skinScan video published 18 January 2013 (https://youtu.be/xyOdAJnIPqA).
SkinVision YouTube video published 17 August 2017 (https://youtu.be/DqrGkJj1eEE).
Risk recommendations as reported by Chadwick and colleagues23 (no specific actions were identified for MelApp).
Ngoo and colleagues24 report results for Dr Mole as percentage of bar filled (continuous risk) and selects cut-off percentage of 72.5% (sensitivity=specificity).